Prostamax 20mg

Prostamax is a short peptide bioregulator developed from research into prostate tissue peptide complexes, commonly described as the tetrapeptide Lys-Glu-Asp-Pro. It belongs to the same family of tissue-specific short peptides as Epithalon and Livagen. Research has focused on prostate tissue function, microcirculation, and age-related changes in the urogenital system.

Chemical Makeup Molecular Formula: C20H33N5O9 | Molecular Weight: 487.51 g/mol | Also known as: KEDP, Lys-Glu-Asp-Pro

Research Highlights

• Tissue Specificity — Research on short peptide bioregulators suggests activity is tissue-directed, with Prostamax investigated specifically in prostate cell and tissue models.
• Prostate Function — Studies have examined the peptide against markers of prostate epithelial and secretory function in aged experimental models.
• Microcirculation — Research suggests possible influence on local blood flow and vascular tone within prostate tissue.
• Inflammatory Markers — Studies report possible reductions in markers associated with chronic prostatic inflammation.
• Gene Regulation — Consistent with the broader short-peptide family, the proposed mechanism involves interaction with DNA and regulation of tissue-specific gene expression.

Available for research and laboratory purposes only.